SARS-CoV-2 Rapid Antigen Test kit Colloidal Gold Method Medical Simple Rapid Convenient Sensitivity : 98.4% Specificity : 98.1% Test Time : 10-15min
FDA EUA
Covid19 Antigen testing kit is used for test patrons on Covid19 symptoms.
PT Taishan Alkes Indonesia is a pioneering company in indonesia producing Rapid Test Swab Antigen and Rapid Test Antibody to detect the Covid-19 virus. PT Taishan Alkes Indonesia products are the work of Indonesian people Our products are made through an effective and efficient production process so as to produce superior quality products according to applicable standards
Corona Antigen Rapid Test Kits USD 4.85 FOB.
#b2b #Manufacturer #Exporter #COVID-19 #Stock #Antigen rapid test kit #anti-epidemic Provide high-quality products at competitive prices Product: SARS-CoV-2 Antigen Rapid Test Kit Standard: CE, FDA certification Packing quantity: 25tests/box FOB: US$1.60/test
COVID finger prick, rapid antigen test, or rapid test, is a rapid diagnostic test suitable for point-of-care testing that directly detects the presence or absence of an antigen. It is commonly used for the detection of SARS-CoV-2, the virus that causes COVID-19. Rapid tests are a type of lateral flow tests that detect protein, distinguishing it from other medical tests that detect antibodies or nucleic acid, of either laboratory or point-of-care types. Rapid tests generally give a result in 1 to 15 minutes, require minimal training or infrastructure, and have significant cost advantages. NO Lab Required for results.
Product Description - SARS-CoV-2 Antigen Rapid Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet Covid-19 clinical criteria. Product origin - Turkey / Istanbul Key Specifications/Special Features - vitro diagnostic , Rapid Antigen Test Kit, SARS-CoV-2, Covid 19 Minimum Order Size and Packaging details - 500
Box size: 400 pieces in a box (individual packaging) Size: 70.3*44.9*32.4cm Weight: 15.5kg TGA certification
For the newly discovered new coronavirus mutant strain Omicron(B.1.1.529),our conducts the sequence comparison analysis of its 32 mutation sites. All mutation sites are outside the epitope region recognized by the new crown paired monoclonal antibody selected by our company.Therefore,according to known academic opinions,the effective production strain for Omicron(B.1.1.529)can still be detected by our product"SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold Immunochromatography)" Next,our will continue to follow up on the mutation of Covid-19perform sequence alignment analysis in timeand evaluate and verify the detection ability of key mutation sites to ensure the sensitivity and specificity of the kit.
